☆ 4.7 Article

B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

GD2-CART cell therapy for H3K27M-mutated diffuse midline gliomas

Robbie G. Majzner et al.

Summary: Diffuse intrinsic pontine glioma (DIPG) and other H3K27M-mutated diffuse midline gliomas (DMGs) are lethal pediatric tumors of the central nervous system. GD2-directed chimeric antigen receptor (CAR) T cells show promising preclinical efficacy. Four patients with H3K27M-mutated DIPG or spinal cord DMG were treated with GD2-CAR T cells and showed clinical and radiographic improvement.

NATURE (2022)

Add to Collection

Article Oncology

Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands

Haeyoun Choi et al.

Summary: This study identifies the ligand-receptor interactions between gamma delta T cells and glioblastoma cells, providing a basis for using gamma delta T cells in glioblastoma treatment. The expression of ligands and cytotoxicity of gamma delta T cells varied among glioblastoma cells, and the cytotoxicity correlated with the expression levels of DNAM-1 ligands. Blocking DNAM-1 decreased gamma delta T cell-mediated cytotoxicity and cytokine secretion. Intratumoral injection of gamma delta T cells showed anti-tumor effects in a mouse model.

ONCOIMMUNOLOGY (2022)

Add to Collection

Article Immunology

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer

Yan Xu et al.

Summary: The study focused on utilizing allogeneic V gamma 9V delta 2 T cells for tumor immunotherapy, developing a novel formula for expanding gamma delta T cells from healthy donors, and conducting clinical trials to prove the safety and efficacy of allogeneic V gamma 9V delta 2 T cells, showing promising results in late-stage cancer patients.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Add to Collection

Review Oncology

Chimeric Antigen Receptor beyond CAR-T Cells

Vicky Mengfei Qin et al.

Summary: Chimeric antigen receptors (CAR) are engineered molecules that can recognize specific antigens and induce downstream signaling, primarily used in CAR-T cells to target and kill tumor cells. While CAR-T cell therapy has shown success in treating hematologic malignancies, current research is focusing on extending CAR technology to other immune cells for potential applications in solid tumors and autoimmune diseases. CAR technology is a powerful platform in immunotherapy with diverse applications beyond conventional CAR-T cells.

CANCERS (2021)

Add to Collection

Review Pharmacology & Pharmacy

CAR-T cells: Early successes in blood cancer and challenges in solid tumors

Hassan Dana et al.

Summary: New approaches in cancer immunotherapy, such as checkpoint inhibitors for solid tumors and CAR-T cell therapy for hematologic malignancies, have shown promising results. While CAR-T products have demonstrated powerful effects against B cell cancers, challenges exist in using them for solid tumors.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Article Neurosciences

The expression of B7-H3 isoforms in newly diagnosed glioblastoma and recurrence and their functional role

Marina Digregorio et al.

Summary: This study identified a subpopulation of GBM cells (SVZ-GBM cells) that have the ability to escape treatment and contribute to tumor recurrence. The protein B7-H3 was found to be specifically expressed by SVZ-GBM cells and may play a crucial role in GBM aggressiveness and recurrence.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application

Masatsugu Miyashita et al.

Summary: Human gamma delta T cells exhibit potent cytotoxicity against various types of cancer cells in an MHC-unrestricted manner. Activation of gamma delta T cells can be achieved via phosphoantigens and N-bis interacting with BTN3A1 on target cells. Co-immunotherapy with gamma delta T cells and immune checkpoint inhibitors may enhance cytotoxicity against cancer cells. Strategies such as the use of bispecific antibodies and chimeric antigen receptors should be further studied in a clinical research setting to overcome current therapeutic limitations.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Oncology

Glioblastoma cells potentiate the induction of the Th1-like profile in phosphoantigen-stimulated γδ T lymphocytes

David A. Rosso et al.

Summary: The study showed that HMBPP-activated V gamma 9V delta 2 T cells exhibit a Th1-like immune response when interacting with GBM cells, and GBM patients have better overall survival when expressing high levels of TRGV9 gene. Additionally, there is an association between gamma delta T cell infiltrates and TNF-alpha expression in the tumor microenvironment.

JOURNAL OF NEURO-ONCOLOGY (2021)

Add to Collection

Review Neurosciences

CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma

Luke Maggs et al.

Summary: GBM is the most common and aggressive malignant primary brain tumor in adults, with current treatment options showing limited efficacy. CAR T cell therapy, which involves genetically modifying T cells to target tumor antigens, has shown promise in hematological malignancies but faces challenges in solid tumors due to factors such as the tumor microenvironment and CAR T cell persistence. Nonetheless, research is ongoing to improve the anti-tumor activity of CAR T cells in GBM treatment.

FRONTIERS IN NEUROSCIENCE (2021)

Add to Collection

Article Immunology

Transcriptome Signature of Vγ9Vδ2 T Cells Treated With Phosphoantigens and Notch Inhibitor Reveals Interplay Between TCR and Notch Signaling Pathways

Ayush Madhok et al.

Summary: The study elucidated the transcriptional changes in Vγ9Vδ2 T cells upon HDMAPP, IPP, and anti-CD3 treatments in combination with IL2 stimulation, as well as the impact of Notch signaling inhibition on these activation treatments. The results highlighted a transcriptional crosstalk between TCR signaling and Notch signaling in Vγ9Vδ2 T cells.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Oncology

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients

Qian-Ting Wang et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)

Add to Collection

Article Multidisciplinary Sciences

Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells

Marc Rigau et al.

SCIENCE (2020)

Add to Collection

Article Oncology

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives

Bas Weenink et al.

CANCERS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors

Johanna Theruvath et al.

NATURE MEDICINE (2020)

Add to Collection

Article Immunology

Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells

Daisuke Okuno et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia

Meir Rozenbaum et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Cell Biology

Patient-derived tumor-like cell clusters for drug testing in cancer therapy

Shenyi Yin et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Isocitrate dehydrogenase 1 mutation enhances 24(S)-hydroxycholesterol production and alters cholesterol homeostasis in glioma

Risheng Yang et al.

ONCOGENE (2020)

Add to Collection

Article Oncology

NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma Cells

Cynthia Chauvin et al.

CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Medicine, General & Internal

B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres

Dean Nehama et al.

EBIOMEDICINE (2019)

Add to Collection

Article Oncology

CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors

Robbie G. Majzner et al.

CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Immunology

Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme

Mijeong Lee et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Oncology

IL-21 Increases the Reactivity of Allogeneic Human V9V2 T Cells Against Primary Glioblastoma Tumors

Noemie Joalland et al.

JOURNAL OF IMMUNOTHERAPY (2018)

Add to Collection

Article Oncology

Survivorship in adults with malignant brain and other central nervous system tumor from 2000-2014

Haley Gittleman et al.

NEURO-ONCOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Ulrich Jarry et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)

Add to Collection

Article Medicine, Research & Experimental

Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation

Sonia Guedan et al.

JCI INSIGHT (2018)

Add to Collection

Review Immunology

Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti-versus Pro-Tumoral Activities

Zheng Xiang et al.

FRONTIERS IN IMMUNOLOGY (2017)

Add to Collection

Article Immunology

Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells

Xiaoying Zhou et al.

Frontiers in Immunology (2017)

Add to Collection

Article Immunology

Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation

Lisa Starick et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2017)

Add to Collection

Article Oncology

NKG2D-and T-cell receptor-dependent lysis of malignant glioma cell lines by human T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors

Guranda Chitadze et al.

ONCOIMMUNOLOGY (2016)

Add to Collection

Review Clinical Neurology

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

ACTA NEUROPATHOLOGICA (2016)

Add to Collection

Review Immunology

γδ T cells in cancer

Bruno Silva-Santos et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Synthesis of a Phosphoantigen Prodrug that Potently Activates Vγ9Vδ2 T-Lymphocytes

Chia-Hung Christine Hsiao et al.

CHEMISTRY & BIOLOGY (2014)

Add to Collection

Article Cell Biology

The effects of age and viral serology on γδ T-cell numbers and exercise responsiveness in humans

Mira Pistillo et al.

CELLULAR IMMUNOLOGY (2013)

Add to Collection

Article Immunology

Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells

Stefano Vavassori et al.

NATURE IMMUNOLOGY (2013)

Add to Collection

Article Oncology

Tumor cell recognition by γδ T lymphocytes T-cell receptor vs. NK-cell receptors

Daniel V. Correia et al.

ONCOIMMUNOLOGY (2013)

Add to Collection

Review Immunology

Human γδ T-cell responses in infection and immunotherapy: Common mechanisms, common mediators?

Chiara Riganti et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2012)

Add to Collection

Article Hematology

Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans

Duane A. Mitchell et al.

BLOOD (2011)

Add to Collection

Article Oncology

Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma

Kim Kramer et al.

JOURNAL OF NEURO-ONCOLOGY (2010)

Add to Collection

Review Immunology

gamma delta T cells as immune effectors against high-grade gliomas

Lawrence S. Lamb

IMMUNOLOGIC RESEARCH (2009)

Add to Collection

Article Oncology

Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma

Nichole L. Bryant et al.

NEURO-ONCOLOGY (2009)

Add to Collection

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.